GNRH1 and endometriosis: In conclusion, the efficacy of OCs, progestagen monotherapy, or GnRH agonists or antagonists on endometriosis-associated pain appears to result from low estrogen concentrations in the ovary, plasma and peritoneal fluid, rather than from a direct progestagenic effect.